Patterns of failure after progressive site‐directed therapy in oligo‐progressive castration‐resistant prostate cancer
- 14 April 2020
- journal article
- editorial
- Published by Wiley in International Journal of Urology
- Vol. 27 (7), 634-635
- https://doi.org/10.1111/iju.14249
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Progressive Site-Directed Therapy for Castration-Resistant Prostate Cancer: Localization of the Progressive Site as a Prognostic FactorInternational Journal of Radiation Oncology*Biology*Physics, 2019
- Stereotactic body radiotherapy for bone oligometastatic disease in prostate cancerWorld Journal of Urology, 2019
- Can Local Ablative Radiotherapy Revert Castration-resistant Prostate Cancer to an Earlier Stage of Disease?European Urology, 2019
- Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017European Urology, 2017
- Utility of computed diffusion‐weighted MRI for predicting aggressiveness of prostate cancerJournal of Magnetic Resonance Imaging, 2017
- METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate CancerEuropean Urology, 2016
- Monitoring the response of bone metastases to treatment with Magnetic Resonance Imaging and nuclear medicine techniques: A review and position statement by the European Organisation for Research and Treatment of Cancer imaging groupEuropean Journal of Cancer, 2014